Zanubrutinib-d5
Zanubrutinib-d5 is deuterium labeled Zanubrutinib. Zanubrutinib is a selective Bruton tyrosine kinase (Btk) inhibitor[1].
Product Specifications
Product Name Alternative
BGB-3111 D5
UNSPSC
12352005
Target
Btk
Type
Isotope-Labeled Compounds
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
99.0
Solubility
DMSO : ≥30 mg/mL (ultrasonic; warming)
Smiles
NC(C1=C2N(N=C1C3=CC=C(OC4=C([2H])C([2H])=C([2H])C([2H])=C4[2H])C=C3)[C@H](C5CCN(C(C=C)=O)CC5)CCN2)=O
Molecular Formula
C27H24D5N5O3
Molecular Weight
476.58
References & Citations
[1]Na Li, et al. Abstract 2597: BGB-3111 is a novel and highly selective Bruton's tyrosine kinase (BTK) inhibitor. Cancer Res 2015;75 (15 Suppl) :Abstract nr 2597.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog